Foghorn Therapeutics Inc. Common Stock is a biotechnology company focused on discovering and developing novel drugs to treat diseases caused by gene dysregulation. With a unique approach and a deep understanding of gene control mechanisms, Foghorn aims to unlock new therapeutic avenues for patients in need.
